HP Liu, JV Zhang, D Wang, A Albrecht… - Journal of Biomedical …, 2022 - Elsevier
Extended endocrine therapy beyond 5 years is of major concern to ER+ breast cancer
survivors. However, it might be unsuitable to apply routinely used genomic tests designed …